Silverarc Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
136,498
-5,304
-4% -$45.3K 0.14% 67
2026
Q1
$779K Sell
141,802
-678,201
-83% -$7.5M 0.08% 69
2025
Q4
$21.6M Sell
820,003
-63,330
-7% -$1.22M 3.01% 11
2025
Q3
$16.9M Buy
883,333
+866,450
+5,132% +$13.5M 2.27% 14
2025
Q2
$328K Sell
16,883
-2,904
-15% -$56.3K 0.06% 59
2025
Q1
$283K Buy
19,787
+5,043
+34% +$96.6K 0.06% 67
2024
Q4
$364K Buy
14,744
+855
+6% +$23.9K 0.08% 59
2024
Q3
$422K Hold
13,889
– – 0.09% 66
2024
Q2
$712K Hold
13,889
– – 0.17% 62
2024
Q1
$1.23M Buy
+13,889
New +$1.4M 0.34% 57

Other funds holding GUTS

Silverarc Capital Management's GUTS Position: Q2 2026 in Review

Silverarc Capital Management reduced its Fractyl Health (GUTS) stake by 3.7% in Q2 2026, selling an estimated $45.3K and leaving 136,498 shares worth $1.3M. The position accounts for 0.14% of the portfolio, ranked #67.

Silverarc Capital Management first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $21.6M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Silverarc Capital Management held 136,498 shares of Fractyl Health worth $1.3M as of Q2 2026.
  • Silverarc Capital Management sold 5,304 Fractyl Health shares in Q2 2026, an estimated $45.3K.
  • Fractyl Health made up 0.14% of Silverarc Capital Management's portfolio in Q2 2026, its #67 holding.
  • Silverarc Capital Management first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • Silverarc Capital Management's Fractyl Health position peaked at $21.6M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.